CA2305031A1 - Control of parasites - Google Patents
Control of parasites Download PDFInfo
- Publication number
- CA2305031A1 CA2305031A1 CA 2305031 CA2305031A CA2305031A1 CA 2305031 A1 CA2305031 A1 CA 2305031A1 CA 2305031 CA2305031 CA 2305031 CA 2305031 A CA2305031 A CA 2305031A CA 2305031 A1 CA2305031 A1 CA 2305031A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- acetate
- cis
- dispenser
- varroa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 244000045947 parasite Species 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 57
- 241000895647 Varroa Species 0.000 claims abstract description 30
- 241000256844 Apis mellifera Species 0.000 claims abstract description 27
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims abstract description 18
- LSTDYDRCKUBPDI-UHFFFAOYSA-N palmityl acetate Chemical compound CCCCCCCCCCCCCCCCOC(C)=O LSTDYDRCKUBPDI-UHFFFAOYSA-N 0.000 claims abstract description 18
- SUCYDSJQVVGOIW-WAYWQWQTSA-N 8Z-Dodecenyl acetate Chemical compound CCC\C=C/CCCCCCCOC(C)=O SUCYDSJQVVGOIW-WAYWQWQTSA-N 0.000 claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- 238000011282 treatment Methods 0.000 claims abstract description 15
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 claims abstract description 14
- 201000002266 mite infestation Diseases 0.000 claims abstract description 11
- OIZXRZCQJDXPFO-UHFFFAOYSA-N Octadecyl acetate Chemical compound CCCCCCCCCCCCCCCCCCOC(C)=O OIZXRZCQJDXPFO-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003620 semiochemical Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 238000013270 controlled release Methods 0.000 claims description 6
- 241000256837 Apidae Species 0.000 claims description 2
- 206010061217 Infestation Diseases 0.000 description 12
- 241000238876 Acari Species 0.000 description 8
- 230000001276 controlling effect Effects 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 239000003016 pheromone Substances 0.000 description 6
- 241000257303 Hymenoptera Species 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 244000144987 brood Species 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
- 230000000895 acaricidal effect Effects 0.000 description 3
- 239000000642 acaricide Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 238000009341 apiculture Methods 0.000 description 2
- 239000005667 attractant Substances 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000275 quality assurance Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- LKMWDVVIKGSQPP-NMUNODQISA-N (z)-dodec-8-en-1-ol;[(e)-dodec-8-enyl] acetate Chemical class CCC\C=C/CCCCCCCO.CCC\C=C\CCCCCCCOC(C)=O LKMWDVVIKGSQPP-NMUNODQISA-N 0.000 description 1
- FAVZTHXOOBZCOB-UHFFFAOYSA-N 2,6-Bis(1,1-dimethylethyl)-4-methyl phenol Natural products CC(C)CC1=CC(C)=CC(CC(C)C)=C1O FAVZTHXOOBZCOB-UHFFFAOYSA-N 0.000 description 1
- 241001580860 Acarapis Species 0.000 description 1
- 239000005652 Acrinathrin Substances 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000264877 Hippospongia communis Species 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- 101100208721 Mus musculus Usp5 gene Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 241001245284 Tropilaelaps clareae Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 241000895650 Varroa jacobsoni Species 0.000 description 1
- FSAVDKDHPDSCTO-WQLSENKSSA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate Chemical compound CCOP(=O)(OCC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl FSAVDKDHPDSCTO-WQLSENKSSA-N 0.000 description 1
- INISTDXBRIBGOC-CGAIIQECSA-N [cyano-(3-phenoxyphenyl)methyl] (2s)-2-[2-chloro-4-(trifluoromethyl)anilino]-3-methylbutanoate Chemical compound N([C@@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-CGAIIQECSA-N 0.000 description 1
- YXWCBRDRVXHABN-JCMHNJIXSA-N [cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-[(z)-2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1C=C(F)C(OC=2C=CC=CC=2)=CC=1C(C#N)OC(=O)C1C(C)(C)C1\C=C(/Cl)C1=CC=C(Cl)C=C1 YXWCBRDRVXHABN-JCMHNJIXSA-N 0.000 description 1
- YLFSVIMMRPNPFK-WEQBUNFVSA-N acrinathrin Chemical compound CC1(C)[C@@H](\C=C/C(=O)OC(C(F)(F)F)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YLFSVIMMRPNPFK-WEQBUNFVSA-N 0.000 description 1
- QXAITBQSYVNQDR-ZIOPAAQOSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 description 1
- 229960002587 amitraz Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- BXNANOICGRISHX-UHFFFAOYSA-N coumaphos Chemical compound CC1=C(Cl)C(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 BXNANOICGRISHX-UHFFFAOYSA-N 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 230000036435 stunted growth Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Abstract
The invention concerns a composition for the treatment of varroa mite infestations in honeybee colonies, comprising an effective amount of at least one compound selected from the group consisting of: cis-8-dodecenyl acetate, 1-dodecanol, n-hexadecyl acetate, n-octadecyl acetate and methyl palmitate.
Description
CONTROL OF PARASITES
The present invention concerns a method for the control of varroa mite infestations of honeybee colonies, and infestation controlling compositions suitable for such purpose.
Varroasis is an infestation of European honeybee colonies (Apis mellifera) with the ecto- , parasitic mites belonging to the order of Acari (Varroa jacobsoni and related species).
The varroa mite originated in Asia and from there has spread to virtually all countries where beekeeping with A. mellifera is practised.
In addition, other acarine infestations such as those of Acarapis woodii (Tracheal mite) and Tropilaelaps clareae can cause significant damage to honeybee colony health.
The varroa mites feed off the haemolymph of the developing bees and adults alike and can result in stunted growth of bees, infection and death of bee colonies. Indeed varroa infestation is the most serious threat to beekeeping world-wide today.
Various treatments are available for the control of this disease. However, in certain countries the varroa mite has developed a resistance to the active ingredient of some of these various treatments, notably to products based on the pyrethroids flumethrin, fluvalinate and acrinathrin, but also to amitraz, coumaphos, malathion, chlorfenvinphos and related molecules.
International patent application W090/04922 describes the use of an extract of bee larvae to attract varroa mites. Such an extract may contain, or be supplemented with, various substances including methyl palmitate. However, the extracts and substances disclosed in W090/04922 are only stated to be useful as attractants; other substances, such as acaricides, are necessary to effect control of mite populations.
There is a need, therefore, for a new treatment for varroa and other infestations.
The present invention concerns a method for the control of varroa mite infestations of honeybee colonies, and infestation controlling compositions suitable for such purpose.
Varroasis is an infestation of European honeybee colonies (Apis mellifera) with the ecto- , parasitic mites belonging to the order of Acari (Varroa jacobsoni and related species).
The varroa mite originated in Asia and from there has spread to virtually all countries where beekeeping with A. mellifera is practised.
In addition, other acarine infestations such as those of Acarapis woodii (Tracheal mite) and Tropilaelaps clareae can cause significant damage to honeybee colony health.
The varroa mites feed off the haemolymph of the developing bees and adults alike and can result in stunted growth of bees, infection and death of bee colonies. Indeed varroa infestation is the most serious threat to beekeeping world-wide today.
Various treatments are available for the control of this disease. However, in certain countries the varroa mite has developed a resistance to the active ingredient of some of these various treatments, notably to products based on the pyrethroids flumethrin, fluvalinate and acrinathrin, but also to amitraz, coumaphos, malathion, chlorfenvinphos and related molecules.
International patent application W090/04922 describes the use of an extract of bee larvae to attract varroa mites. Such an extract may contain, or be supplemented with, various substances including methyl palmitate. However, the extracts and substances disclosed in W090/04922 are only stated to be useful as attractants; other substances, such as acaricides, are necessary to effect control of mite populations.
There is a need, therefore, for a new treatment for varroa and other infestations.
Summary of the Invention It has now been found that the varroa mite infestation in bee-hives can be efficiently controlled by applying to the beehives an effective amount of at least one compound selected from the group consisting of: cis-8-dodecenyl acetate, 1-dodecanol, n-hexadecyl acetate, n-octadecyl acetate and methyl palmitate.
In a first aspect, therefore, the invention provides a composition for controlling varroa mite infestations in a honeybee colony, comprising an effective amount of at least one compound selected from the group consisting of: cis-8-dodecenyl acetate, 1-dodecanol, n-hexadecyl acetate and n-octadecyl acetate.
Preferably, the composition consists essentially of cis-8-dodecenyl acetate.
Other compounds, selected from the group consisting of 1-dodecanol, n-hexadecyl acetate, n-1 ~ octadecyl acetate and excipients, may be included. Advantageously, the composition comprises about 50% cis-8-dodecenyl acetate, preferably about 60% cis-8-dodecenyl acetate, more preferably about 70% cis-8-dodecenyl acetate and ideally about 85% cis-8-dodecenyl acetate or more.
Preferably, the composition according to the invention is provided in a suitable dispenser, as used for dispersion of pheromones and other semiochemicals.
The invention therefore provides a dispenser for the controlled release of semiochemicals to the locus of a bee colony, said dispenser containing and releasing a composition according to the invention.
In order to achieve the treatment of varroa mite infestations, release of the composition should take place over a period of a minimum of two months. Preferably, the composition is released over a period of two to three months. This requires the dispenser to contain between O.lmg and l5mg of the composition. Preferably, it contains lmg to l Omg of the composition. Preferably, it contains lmg to Smg of the composition.
In a first aspect, therefore, the invention provides a composition for controlling varroa mite infestations in a honeybee colony, comprising an effective amount of at least one compound selected from the group consisting of: cis-8-dodecenyl acetate, 1-dodecanol, n-hexadecyl acetate and n-octadecyl acetate.
Preferably, the composition consists essentially of cis-8-dodecenyl acetate.
Other compounds, selected from the group consisting of 1-dodecanol, n-hexadecyl acetate, n-1 ~ octadecyl acetate and excipients, may be included. Advantageously, the composition comprises about 50% cis-8-dodecenyl acetate, preferably about 60% cis-8-dodecenyl acetate, more preferably about 70% cis-8-dodecenyl acetate and ideally about 85% cis-8-dodecenyl acetate or more.
Preferably, the composition according to the invention is provided in a suitable dispenser, as used for dispersion of pheromones and other semiochemicals.
The invention therefore provides a dispenser for the controlled release of semiochemicals to the locus of a bee colony, said dispenser containing and releasing a composition according to the invention.
In order to achieve the treatment of varroa mite infestations, release of the composition should take place over a period of a minimum of two months. Preferably, the composition is released over a period of two to three months. This requires the dispenser to contain between O.lmg and l5mg of the composition. Preferably, it contains lmg to l Omg of the composition. Preferably, it contains lmg to Smg of the composition.
It is envisaged that a dispenser containing an amount of the composition may comprise two dispensers, each containing half said amount of the composition, for example a dispenser containing l5mg of the composition may comprise two dispensers, each containing about 7.~mg of the composition. Similarly, a dispenser containing lOmg of the composition may comprise two dispensers, each containing about Smg of the composition.
According to a further aspect, the invention provides the use of an effective amount of at least one compound selected from the group consisting of cis-8-dodecenyl acetate, 1-dodecanol, n-hexadecyl acetate, n-octadecyl acetate and methyl palmitate for the treatment of varroa mite infestations in honeybee colonies.
In accordance with the present invention, the term "treatment" means the reduction of the numbers of the mites which infest the honeybee colonies. Thus, compositions according to the invention are effective to limit population growth of the mites and, indirectly, cause the death thereof. The compositions do not merely function as attractants, requiring the presence of other agents to provide control of the mite population.
According to a still further aspect, the invention relates to a method for the control of varroa mite infestations in honeybee colonies, comprising applying to the honeybee colonies an effective amount of at least one compound selected from the group consisting of cis-8-dodecenyl acetate, 1-dodecanol, n-hexadecyl acetate, n-octadecyl acetate and methyl palmitate.
Preferably, the concentration of the composition in the environment of the bee colony is held at an efficacious level for at least two months, advantageously two to three months.
This may be accomplished using a single application of composition according to the invention, or may be accomplished using more than one application of a composition according to the invention, for example two applications or even more. In the case of using two or more applications, such applications may be made simultaneously, sequentially or together.
According to a further aspect, the invention provides the use of an effective amount of at least one compound selected from the group consisting of cis-8-dodecenyl acetate, 1-dodecanol, n-hexadecyl acetate, n-octadecyl acetate and methyl palmitate for the treatment of varroa mite infestations in honeybee colonies.
In accordance with the present invention, the term "treatment" means the reduction of the numbers of the mites which infest the honeybee colonies. Thus, compositions according to the invention are effective to limit population growth of the mites and, indirectly, cause the death thereof. The compositions do not merely function as attractants, requiring the presence of other agents to provide control of the mite population.
According to a still further aspect, the invention relates to a method for the control of varroa mite infestations in honeybee colonies, comprising applying to the honeybee colonies an effective amount of at least one compound selected from the group consisting of cis-8-dodecenyl acetate, 1-dodecanol, n-hexadecyl acetate, n-octadecyl acetate and methyl palmitate.
Preferably, the concentration of the composition in the environment of the bee colony is held at an efficacious level for at least two months, advantageously two to three months.
This may be accomplished using a single application of composition according to the invention, or may be accomplished using more than one application of a composition according to the invention, for example two applications or even more. In the case of using two or more applications, such applications may be made simultaneously, sequentially or together.
Detailed Description of the Invention For the purpose of this invention, the locus of colonies of honeybees is usually understood to be, without implying a limitation, beehives, or similar containers where colonies of bees build their breeding places, such as honeycombs. Preferably, the locus of honeybee colonies as referred to herein is a beehive.
Compositions A composition according to the present invention may be a pure compound, or a mixture of compounds. Compositions according to the invention are typically formulated from high purity starting materials, available commercially from specialist manufacturers.
Typically, the compositions consist essentially of the active ingredients in substantially pure form. The preparation may also include one or more anti-oxidants such as Butylated Hydroxytoluene (BHT), 2,6-Bis(1,1-dimethyl-ethyl)-4-methylphenol.
An "effective amount" of a compound component of the composition according to the present invention is an amount which, in the relevant composition, is sufficient for effective control of varroa mite infestations, as defined below. For example, the composition may comprise about 80% to 100% of the selected active compound(s).
Advantageously, the composition comprises about 85% or more cis-8-dodecenyl acetate.
The composition may comprise or consist essentially of any one of the compounds according to the present invention, or any two or more of said compounds. In addition, the composition may include one or more excipients, which may be solvents, thickeners, and the like.
In a preferred embodiment, methods according to the present invention comprise the application of only a single semiochemical substance. Alternatively, however, mixtures of two or more semiochemical substances may be used. Optionally, the method may entail the application of a mixture of semiochemicals.
S
Dispenser Dispensers are widely used in the art to distribute semiochemicals to lepidopteran and coleopteran populations. Generally, a dispenser may be any medium suitable for dispersing a composition according to the present invention characterised in that it provides a more regulated administration of active material over a given time-frame in comparison to raw active material. In particular, such are preferably capable of maintaining a relatively constant vapour concentration of the semiochemical(s) in the atmosphere of an enclosed volume of a bee habitat, i.e. a beehive.
The composition of the invention is transported from the dispenser via the vapour phase to the varroa mites. In a preferred aspect of the invention, the composition evaporates or sublimates from the dispenser in a regulated concentration into the atmosphere of the bee environment (e.g. the beehive) and maintains the preselected concentration for at least a 2 month treatment period. Though the atmosphere in the bee environment is not hermetically sealed, the population increase of the varroa mites in said environment can be effectively controlled by the release of the composition from the dispenser.
The method of control of varroa infestations according to the present invention is both effective against acaricide-resistant and acaricide-susceptible varroa mite strains in beehives. In a preferred embodiment of the invention, effective control of mite poulations, particularly varroa poulations, may be achieved such that the infestation is reduced to a level of 50% or less of a starting infestation level. The "starting infestation level" is the infestation level before treatment is initiated. Preferably, the reduction in infestation levels to 50% is achieved within two months. Advantageously, varroa populations are reduced by between 60% and 80%, and preferably between 80% and 95%.
At higher dispenser loadings in particular, the invention is capable of reducing varroa mite populations by at least 80%, preferably about 90% and optimally about 95%.
Dispensers are known in the art which may be employed with the compositions of the present invention. For example, dispensers are known as manufactured by Shin-Etsu Chemical Co., Japan, for instance as described in US 4,325941 and US
Compositions A composition according to the present invention may be a pure compound, or a mixture of compounds. Compositions according to the invention are typically formulated from high purity starting materials, available commercially from specialist manufacturers.
Typically, the compositions consist essentially of the active ingredients in substantially pure form. The preparation may also include one or more anti-oxidants such as Butylated Hydroxytoluene (BHT), 2,6-Bis(1,1-dimethyl-ethyl)-4-methylphenol.
An "effective amount" of a compound component of the composition according to the present invention is an amount which, in the relevant composition, is sufficient for effective control of varroa mite infestations, as defined below. For example, the composition may comprise about 80% to 100% of the selected active compound(s).
Advantageously, the composition comprises about 85% or more cis-8-dodecenyl acetate.
The composition may comprise or consist essentially of any one of the compounds according to the present invention, or any two or more of said compounds. In addition, the composition may include one or more excipients, which may be solvents, thickeners, and the like.
In a preferred embodiment, methods according to the present invention comprise the application of only a single semiochemical substance. Alternatively, however, mixtures of two or more semiochemical substances may be used. Optionally, the method may entail the application of a mixture of semiochemicals.
S
Dispenser Dispensers are widely used in the art to distribute semiochemicals to lepidopteran and coleopteran populations. Generally, a dispenser may be any medium suitable for dispersing a composition according to the present invention characterised in that it provides a more regulated administration of active material over a given time-frame in comparison to raw active material. In particular, such are preferably capable of maintaining a relatively constant vapour concentration of the semiochemical(s) in the atmosphere of an enclosed volume of a bee habitat, i.e. a beehive.
The composition of the invention is transported from the dispenser via the vapour phase to the varroa mites. In a preferred aspect of the invention, the composition evaporates or sublimates from the dispenser in a regulated concentration into the atmosphere of the bee environment (e.g. the beehive) and maintains the preselected concentration for at least a 2 month treatment period. Though the atmosphere in the bee environment is not hermetically sealed, the population increase of the varroa mites in said environment can be effectively controlled by the release of the composition from the dispenser.
The method of control of varroa infestations according to the present invention is both effective against acaricide-resistant and acaricide-susceptible varroa mite strains in beehives. In a preferred embodiment of the invention, effective control of mite poulations, particularly varroa poulations, may be achieved such that the infestation is reduced to a level of 50% or less of a starting infestation level. The "starting infestation level" is the infestation level before treatment is initiated. Preferably, the reduction in infestation levels to 50% is achieved within two months. Advantageously, varroa populations are reduced by between 60% and 80%, and preferably between 80% and 95%.
At higher dispenser loadings in particular, the invention is capable of reducing varroa mite populations by at least 80%, preferably about 90% and optimally about 95%.
Dispensers are known in the art which may be employed with the compositions of the present invention. For example, dispensers are known as manufactured by Shin-Etsu Chemical Co., Japan, for instance as described in US 4,325941 and US
5,503,839; or US
5,000, 987 (Nitto Denko Corporation).
US 5,750,129 describes a number of dispensers. Zeoli, L.T., et al., 1982 ("Controlled Release Technologies" in Insect Suppression with Controlled Release Pheromone Systems, vol. 1, ed. G. Zweig, CRC Press Inc., Boca Raton, FL. pp. 131-144) have summarised controlled release technologies used for delivering semiochemicals and have categorised the dispensers types into four groups: monolithic systems, laminated structures, reservoir systems without rate controlling membranes and reservoir systems with rate controlling membranes.
Monolithic systems are one material systems which consist of inert polymeric matrices impregnated with the semiochemical as the active ingredient. Such homogenous devices are simple and they lend themselves to a number of applications. Examples of this technology are polyvinylchloride (PVC) impregnated with semiochemical (Fitzgerald, T.D. et al., 1973: Environmental Entomology, vol. 2, #4, pp. 607-610) or silicone rubber impregnated with fragrances as in U.S 4,725,575 (Union Camp Co.), or silicone-urethane copolymers used as matrices for dispensing fragrances or pheromones as in U.S.
4,908,208 and 5,008115 (Dow Corning Co.), urethane matrices for dispensing pesticides as in U.S. 4,594,380 (AT & T Bell Laboratories) or acrylate polymers impregnated with pheromones (Smith C.N. et al., 1991: Intern. Symp. Control Rel. Bioact.
Mater., Controlled Release Society, Inc. pp. 81-82; Kim, J. et al., 1988: Appl.
Radiat. Isot., vol.
39, #11, pp. 1145- 1152).
Laminated structures are devices which have relatively good release characteristics, approaching zero order (constant) release. The manufacture of these devices requires multiple processing to produce the laminate. An example of this technology are laminated dispensers described in US 4,639,393 (Herculite Protective Fabrics), and DE
3524180 (Montedison S.p.A.).
Reservoir systems without rate controlling membranes can be exemplified by capillary release devices as described in US 4,017,030 (Albany International Co.).
Reservoir systems with a rate controlling membrane generally provide near constant release characteristics which are governed by a permeable membrane. The membrane composition and surface area can be varied to effect changes in the release rates.
Examples are described in US 4,323,556 (Montedison S.p.A.), US 4,445,641 (Bend Research Inc.), US 4,979,673 (I. J. Wilk), US 4,923,119 (Shin-Etsu Chemical Co.), U.S.
4,793,555 (Dow Corning Corp.) and DE 2945655 (Celamerck G.m.b.H.).
Dispensers such as rubber septa or polyisoprene type septa of a variety of size/dimension as are traditionally used to liberate lepidopteran and coleopteran pheromones may be employed in this invention. In addition traditional "Long Life" lepidopteran or coleopteran pheromone dispensers, such as small polyethylene or other polymer tubes with or without internal wicks and closures may be used as dispensers for this invention.
Dispensers according to the invention are preferably loaded with 0.1 mg to 1 Omg or more of the composition of the invention. Although amounts as low as 0.1 mg (or lower) may be effective, higher loadings are more effective over a longer time period.
The minimum treatment period is of the order of two months, with between two and three months being preferred.
Control of varroa mites The present invention is effective in the control of varroa mites in the presence of bee brood. In the normal varroa life cycle, fecund female varroa mites enter the cells of the brood before they are capped over by the worker bees. After a period of rest the female mite begins to feed off the developing bee pupa and only then can lay eggs.
In the presence of compositions according to the invention, the mites are deterred from going into the bee brood cells. They do not feed off the brood and therefore cannot lay eggs. This probably leads to starvation of the mites, as they are unable to feed effectively off adult bees, with possible disturbance to other metabolic processes of the mites. After about 8 days of treatment with the invention, mites begin to die and accumulate at the bottom of the hive.
g Thus, the invention successfully alters varroa mite behaviour such that they are unable to reproduce or feed, and leads to control of varroa infestations without the use of traps, acaricides or other toxic chemicals.
The invention is further described below, for the purpose of illustrration only, in the , following examples.
Example 1: Preparation of a Composition comprising cis-8-dodecenyl acetate The starting materials (individual pheromone components) are obtained commercially in a highly pure form. A blend of the components to the prescribed ratio and formula is made up as a dosing solution. This is analysed by chromatographic methods as part of the Quality Assurance procedure prior to dosing the septa.
Example 2: Dispersion Formulations in a dispenser A dosing solution will have been determined and verified previously under the Quality Assurance procedure. The individual dispensers are then dosed to the correct loading using accurate micropippette or automated dosing devices. Samples of such dosed dispensers are examined and analysed afterwards against the known specification.
Provided the specification is met the dispensers are released for use.
All publications mentioned in the above specification are herein incorporated by reference. Various modifications and variations of the described methods and system of the invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the described modes for carrying out the invention which are obvious to those skilled in the art are intended to be within the scope of the following claims.
5,000, 987 (Nitto Denko Corporation).
US 5,750,129 describes a number of dispensers. Zeoli, L.T., et al., 1982 ("Controlled Release Technologies" in Insect Suppression with Controlled Release Pheromone Systems, vol. 1, ed. G. Zweig, CRC Press Inc., Boca Raton, FL. pp. 131-144) have summarised controlled release technologies used for delivering semiochemicals and have categorised the dispensers types into four groups: monolithic systems, laminated structures, reservoir systems without rate controlling membranes and reservoir systems with rate controlling membranes.
Monolithic systems are one material systems which consist of inert polymeric matrices impregnated with the semiochemical as the active ingredient. Such homogenous devices are simple and they lend themselves to a number of applications. Examples of this technology are polyvinylchloride (PVC) impregnated with semiochemical (Fitzgerald, T.D. et al., 1973: Environmental Entomology, vol. 2, #4, pp. 607-610) or silicone rubber impregnated with fragrances as in U.S 4,725,575 (Union Camp Co.), or silicone-urethane copolymers used as matrices for dispensing fragrances or pheromones as in U.S.
4,908,208 and 5,008115 (Dow Corning Co.), urethane matrices for dispensing pesticides as in U.S. 4,594,380 (AT & T Bell Laboratories) or acrylate polymers impregnated with pheromones (Smith C.N. et al., 1991: Intern. Symp. Control Rel. Bioact.
Mater., Controlled Release Society, Inc. pp. 81-82; Kim, J. et al., 1988: Appl.
Radiat. Isot., vol.
39, #11, pp. 1145- 1152).
Laminated structures are devices which have relatively good release characteristics, approaching zero order (constant) release. The manufacture of these devices requires multiple processing to produce the laminate. An example of this technology are laminated dispensers described in US 4,639,393 (Herculite Protective Fabrics), and DE
3524180 (Montedison S.p.A.).
Reservoir systems without rate controlling membranes can be exemplified by capillary release devices as described in US 4,017,030 (Albany International Co.).
Reservoir systems with a rate controlling membrane generally provide near constant release characteristics which are governed by a permeable membrane. The membrane composition and surface area can be varied to effect changes in the release rates.
Examples are described in US 4,323,556 (Montedison S.p.A.), US 4,445,641 (Bend Research Inc.), US 4,979,673 (I. J. Wilk), US 4,923,119 (Shin-Etsu Chemical Co.), U.S.
4,793,555 (Dow Corning Corp.) and DE 2945655 (Celamerck G.m.b.H.).
Dispensers such as rubber septa or polyisoprene type septa of a variety of size/dimension as are traditionally used to liberate lepidopteran and coleopteran pheromones may be employed in this invention. In addition traditional "Long Life" lepidopteran or coleopteran pheromone dispensers, such as small polyethylene or other polymer tubes with or without internal wicks and closures may be used as dispensers for this invention.
Dispensers according to the invention are preferably loaded with 0.1 mg to 1 Omg or more of the composition of the invention. Although amounts as low as 0.1 mg (or lower) may be effective, higher loadings are more effective over a longer time period.
The minimum treatment period is of the order of two months, with between two and three months being preferred.
Control of varroa mites The present invention is effective in the control of varroa mites in the presence of bee brood. In the normal varroa life cycle, fecund female varroa mites enter the cells of the brood before they are capped over by the worker bees. After a period of rest the female mite begins to feed off the developing bee pupa and only then can lay eggs.
In the presence of compositions according to the invention, the mites are deterred from going into the bee brood cells. They do not feed off the brood and therefore cannot lay eggs. This probably leads to starvation of the mites, as they are unable to feed effectively off adult bees, with possible disturbance to other metabolic processes of the mites. After about 8 days of treatment with the invention, mites begin to die and accumulate at the bottom of the hive.
g Thus, the invention successfully alters varroa mite behaviour such that they are unable to reproduce or feed, and leads to control of varroa infestations without the use of traps, acaricides or other toxic chemicals.
The invention is further described below, for the purpose of illustrration only, in the , following examples.
Example 1: Preparation of a Composition comprising cis-8-dodecenyl acetate The starting materials (individual pheromone components) are obtained commercially in a highly pure form. A blend of the components to the prescribed ratio and formula is made up as a dosing solution. This is analysed by chromatographic methods as part of the Quality Assurance procedure prior to dosing the septa.
Example 2: Dispersion Formulations in a dispenser A dosing solution will have been determined and verified previously under the Quality Assurance procedure. The individual dispensers are then dosed to the correct loading using accurate micropippette or automated dosing devices. Samples of such dosed dispensers are examined and analysed afterwards against the known specification.
Provided the specification is met the dispensers are released for use.
All publications mentioned in the above specification are herein incorporated by reference. Various modifications and variations of the described methods and system of the invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the described modes for carrying out the invention which are obvious to those skilled in the art are intended to be within the scope of the following claims.
Claims (11)
1. A composition for the treatment of varroa mite infestations in honeybee colonies, comprising an effective amount of at least one compound selected from the group consisting of: cis-8-dodecenyl acetate, 1-dodecanol, n-hexadecyl acetate and n-octadecyl acetate.
2. A composition according to Claim 1, consisting essentially of cis-8-dodecenyl acetate.
3. A composition according to claim 2, comprising about 85% by volume of cis-8-dodecenyl acetate.
4. A dispenser for the controlled release of semiochemicals to the locus of a bee colony, said dispenser containing and releasing a composition according to any preceding claim.
5. A dispenser according to claim 4, which is capable of delivering an effective amount of the composition over a period of at least two months.
6. A dispenser according to claim 4 or claim 5, containing 0.1-15mg of the composition.
7. A dispenser according to claim 6, containing 1-10 mg of the composition.
8. A dispenser according to claim 7, containing 1-5 mg of the composition.
9. A method for the treatment of varroa mite infestations in colonies of honeybees, comprising the application of an effective amount at a composition comprising least one compound selected from the group consisting of: cis-8-dodecenyl acetate, 1-dodecanol, n-hexadecyl acetate, methyl palmitate and n-octadecyl acetate of to the locus of the honeybee colonies.
10 10. A method according to claim 9, wherein the concentration of the composition in the environment of the bee colony is kept at an efficacious level over a 2-3month treatment period.
11. Use of an effective amount of at least one compound selected from the group consisting of cis-8-dodecenyl acetate, 1-dodecanol, n-hexadecyl acetate, n-octadecyl acetate and methyl palmitate for the treatment of varroa mite infestations in honeybee colonies.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0003769.7 | 2000-02-18 | ||
GB0003769A GB0003769D0 (en) | 2000-02-18 | 2000-02-18 | Control of parasites |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2305031A1 true CA2305031A1 (en) | 2001-08-18 |
Family
ID=9885871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2305031 Abandoned CA2305031A1 (en) | 2000-02-18 | 2000-04-11 | Control of parasites |
Country Status (2)
Country | Link |
---|---|
CA (1) | CA2305031A1 (en) |
GB (1) | GB0003769D0 (en) |
-
2000
- 2000-02-18 GB GB0003769A patent/GB0003769D0/en not_active Ceased
- 2000-04-11 CA CA 2305031 patent/CA2305031A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
GB0003769D0 (en) | 2000-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0869714B1 (en) | Method for the control of infestations of honeybee colonies | |
Böhme et al. | From field to food—will pesticide-contaminated pollen diet lead to a contamination of royal jelly? | |
Tasei et al. | Sub‐lethal effects of imidacloprid on bumblebees, Bombus terrestris (Hymenoptera: Apidae), during a laboratory feeding test | |
Calderone et al. | Plant extracts for control of the parasitic mite Varroa jacobsoni (Acari: Varroidae) in colonies of the western honey bee (Hymenoptera: Apidae) | |
Aupinel et al. | Toxicity of dimethoate and fenoxycarb to honey bee brood (Apis mellifera), using a new in vitro standardized feeding method | |
Dai et al. | Effects of sublethal concentrations of bifenthrin and deltamethrin on fecundity, growth, and development of the honeybee Apis mellifera ligustica | |
US5230894A (en) | Acaricidal composition suitable for use against varroatosis in bees and device containing same | |
Colin et al. | Fluvalinate resistance of Varroa jacobsoni Oudemans (Acari: Varroidae) in mediterranean apiaries of France | |
Aliano et al. | Acute contact toxicity of oxalic acid to Varroa destructor (Acari: Varroidae) and their Apis mellifera (Hymenoptera: Apidae) hosts in laboratory bioassays | |
US6190652B1 (en) | Volatiles of Japanese honeysuckle flowers as attractants for adult Lepidopteran insects | |
CA2344547A1 (en) | Chemical attractants for moths | |
RIETH et al. | The repellent effect of two pyrethroid insecticides on the honey bee | |
Ruther et al. | Response of garden chafer, Phyllopertha horticola, to plant volatiles: from screening to application | |
Poullot et al. | Is attract‐and‐kill technology potent against insecticide‐resistant Lepidoptera? | |
Wakamura et al. | Sex pheromone of the black cutworm moth, Agrotis ipsilon Hufnagel (Lepidoptera: Noctuidae): Attractant synergist and improved formulation | |
Rice et al. | Comparison of release mechanisms for botanical oils to control Varroa destructor (Acari: Varroidae) and Acarapis woodi (Acari: Tarsonemidae) in colonies of honey bees (Hymenoptera: Apidae) | |
Hammack | Volatile semiochemical impact on trapping and distribution in maize of northern and western corn rootworm beetles (Coleoptera: Chrysomelidae) | |
CA2305031A1 (en) | Control of parasites | |
WO2009059415A1 (en) | Slow-release device for delivering stabilized honey bee brood pheromone within the hive | |
KR100479254B1 (en) | How to curb bee bee infection | |
Rieth et al. | Repellency of two phenylacetate-ester pyrethroids to the honeybee | |
US11540515B2 (en) | Use of dialkoxybenzenes for control of honey bee mite varroa destructor | |
CN113874028A (en) | Prevention of bee disease | |
Stoner et al. | Microencapsulated Methyl Parathion (Penncap-M®): Effect of Long-Term Feeding of Low Doses in Pollen on Honey Bees (Hymenoptera: Apidae) in Standard-Size Field Colonies | |
Meinke | Potential of starch encapsulated semiochemical/insecticide formulations for corn rootworm control |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |